BACKGROUND In hemodialyzed patient, we can often seethe complication (ex. Hypotension, bad feeling) in hemodialysis (HD) after cardiac catheterization. So we made modification for HD after the first time cardiac catheterization. Content of the modify HD are that the blood osmolality was changed slowly. (HD group: 157 patients). From January 2013 to August 2014 we performed modified HD after that (mHD group: 61 patients). Content of modify were that we decreased dialysis flow rate (300 ml/min) in anterior half of HD; in posterior half we performed ordinary HD. The definition of the complication are discontinuity of HD from hypotension or/and bad feeling, Unattainable of defecated water and requisition of infusion solution.
METHODS
The candidate was our consecutive HD patients (218 patients, 157 male, 67.1 AE 9.8 y.o.) who performed cardiac catheterization from February 2009 to August 2014 . From February 2009 to December 2012 we performed usual HD after cardiac catheterization (HD group: 157 patients) . From January 2013 to August 2014 we performed modified HD after that (mHD group: 61 patients). Content of modify were that we decreased dialysis flow rate (300 ml/min) in anterior half of HD; in posterior half we performed ordinary HD. The definition of the complication are discontinuity of HD from hypotension or/and bad feeling, Unattainable of defecated water and requisition of infusion solution.
RESULTS Developed the complication of HD group was 59 patients (37.6 %), mHD group was 7 patients (11.3 %). It was significant difference between the groups (p¼0.00013).
CONCLUSION Our Modifying, the blood osmolality was changed slowly, of HD after the first time cardiac catheterization was useful for reducing the rate complication. The procedure could not be completed in one patient due to hemodynamically unstable incessant ventricular tachycardia. Subsequently 35 patients were followed up for next 5 years both clinically and with echocardiography.
HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY

RESULTS
The mean age at intervention was 32AE10 years. The peak dynamic LVOT gradient pre-operatively was 73AE20 mm Hg. Alcohol septal ablation was performed successfully in all 35 patients with immediate LVOT gradient reduction. The peak LVOT gradient postoperatively was 13AE7 mm of Hg. Three patients developed complete heart block during the procedure, among which 2 patients reverted back spontaneously to sinus rhythm within 72 hours. One patient did not revert back and permanent pacemaker was implanted. Over next 5-8 years follow up 4 patients died (2 patients with refractory heart failure, 2 patients with sudden cardiac death). Three patients developed atrial fibrillation over follow up. Rest of the patients is doing well symptomatically and echocardiography showed no recurrence of significant LVOT obstruction.
CONCLUSION HCM is a complex genetic disorder with several long term complications especially in the obstructive variety. Though it is said to reserve alcohol septal ablation (Class IIa) only for those who are not suitable candidates for surgical mectomy, a large group of symptomatic patients who refuse for surgical option can also be treated successfully with alcohol septal ablation. The immediate and long-term outcome is good. BACKGROUND Thoracic endovascular aortic repair (TEVAR) shows limitations in cases where the aortic pathology involves the aortic arch and only a short proximal landing zone is thereby available for the stent graft. In our previous study, we developed a round shape fenestrated aortic arch stent graft (FASG) with a preloaded catheter for protecting branch arteries. But, FASG with round shape fenestration is not available in case of emergency as aortic rupture, complicated aortic dissection because FASG with round shape fenestration is manufactured individually. In this study, we developed a window shape FASC with a preloaded catheter for protecting branch arteries and performed a preclinical study with this device in swine.
INNOVATIVE DEVICES AND FUTURISTIC THERAPIES (TCTAP A-074 TO TCTAP A-075)
METHODS
The FASG is a self-expandable nitinol-PTEF stent graft with window shape fenestration and preloading catheter that is designed to access right carotid artery safely. We design a window shaped fenestration and preloading catheter placed inside the stent graft to save blood flow to the carotid, left subclavian arteries. After window shape FASG is partially deployed, 0.35 inch guidewire is placed into the right carotid artery and then stent graft is fully deployed. Following separate stent graft for right carotid artery is deployed. The sizes of fenestrated window were 30mm in width, 15mm in length and 40mm in width, 15mm in length. Six FASGs with window shaped fenestration and a side branch stent graft were advanced through the iliac artery in 6 swines weighing 70-80 kg. The presence of endoleaks and the patency and deformity of the grafts were examined with digital subtraction angiography (DSA) at 4 weeks postoperatively. A postmortem examination was performed at 8 weeks to evaluate the gross morphology, patency, and deformity of the FASGs with window shaped fenestration. 
